In this article, we take a look back at this year's top Oliver Wyman Health articles of 2018. Topics include healthcare predictions and view of the future market, payer-provider partnerships, disruptive healthcare models, accountable care organization challenges, and more!
In the wake of disruption from industries like retail and finance, healthcare incumbents must anticipate disruption from the side or above, not just head-on. This practical action plan for regional healthcare incumbents offers an examination of your organization's two-year, five-year, and ten-year plan.
Over the past decade, pharma has seen an explosion of new acquisitions and alliances. The pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
Oliver Wyman shares five key takeaways on healthcare’s consumer-centric shift on the Wharton University of Pennsylvania Business Radio on Sirius XM. We discuss how healthcare’s consumer shift happened in the first place, who the big players are, and what the future of consumer-centric healthcare may look like.
Aledade leadership shares three aspects hindering accountable care organization adoption among health plans. Says Aledade, employers must focus on "value" instead of "volume discounts."
These are scary times for Blue plans. And, these are exciting times for Blue plans. Here's our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
It's time to redefine what competition looks like. From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.
Analysis on the potential effects of cost-sharing reduction payments and pass-through savings.
Over the past six years, Oliver Wyman has been tracking payer-provider partnerships and reporting on trends in the space. Here's a detailed look at the 22 payer-provider partnerships created in Q1 of 2018.
It's not easy to predict the future of Amazon, Berkshire Hathaway, and JPMorgan. But it is easy to see why incumbents should be making disruption a top priority. If this joint venture is your future competition, you need to go further and move faster.
In our most popular article of the year, we dug deep to analyze what the industry can expect in mergers and acquisitions, investments, pharma, and much more.